These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 29950350

  • 1. IFNγ-induced Chemokines Are Required for CXCR3-mediated T-Cell Recruitment and Antitumor Efficacy of Anti-HER2/CD3 Bispecific Antibody.
    Li J, Ybarra R, Mak J, Herault A, De Almeida P, Arrazate A, Ziai J, Totpal K, Junttila MR, Walsh KB, Junttila TT.
    Clin Cancer Res; 2018 Dec 15; 24(24):6447-6458. PubMed ID: 29950350
    [Abstract] [Full Text] [Related]

  • 2. A novel asymmetrical anti-HER2/CD3 bispecific antibody exhibits potent cytotoxicity for HER2-positive tumor cells.
    Yu S, Zhang J, Yan Y, Yao X, Fang L, Xiong H, Liu Y, Chu Q, Zhou P, Wu K.
    J Exp Clin Cancer Res; 2019 Aug 14; 38(1):355. PubMed ID: 31412896
    [Abstract] [Full Text] [Related]

  • 3. IL-15/IL-15Rα-Fc-Fusion Protein XmAb24306 Potentiates Activity of CD3 Bispecific Antibodies through Enhancing T-Cell Expansion.
    Li J, Clark R, Slaga D, Avery K, Liu K, Schubbert S, Varma R, Chiang E, Totpal K, Bernett MJ, Holder PG, Junttila TT.
    Mol Cancer Ther; 2024 Sep 04; 23(9):1305-1316. PubMed ID: 38739434
    [Abstract] [Full Text] [Related]

  • 4. Relative Target Affinities of T-Cell-Dependent Bispecific Antibodies Determine Biodistribution in a Solid Tumor Mouse Model.
    Mandikian D, Takahashi N, Lo AA, Li J, Eastham-Anderson J, Slaga D, Ho J, Hristopoulos M, Clark R, Totpal K, Lin K, Joseph SB, Dennis MS, Prabhu S, Junttila TT, Boswell CA.
    Mol Cancer Ther; 2018 Apr 04; 17(4):776-785. PubMed ID: 29339550
    [Abstract] [Full Text] [Related]

  • 5. Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation.
    Zhou S, Meng F, Du S, Qian H, Ding N, Sha H, Zhu M, Yu X, Wang L, Liu B, Wei J.
    J Immunother Cancer; 2021 May 04; 9(5):. PubMed ID: 33986122
    [Abstract] [Full Text] [Related]

  • 6. Antitumor efficacy of a bispecific antibody that targets HER2 and activates T cells.
    Junttila TT, Li J, Johnston J, Hristopoulos M, Clark R, Ellerman D, Wang BE, Li Y, Mathieu M, Li G, Young J, Luis E, Lewis Phillips G, Stefanich E, Spiess C, Polson A, Irving B, Scheer JM, Junttila MR, Dennis MS, Kelley R, Totpal K, Ebens A.
    Cancer Res; 2014 Oct 01; 74(19):5561-71. PubMed ID: 25228655
    [Abstract] [Full Text] [Related]

  • 7. STAT3 in CD8+ T Cells Inhibits Their Tumor Accumulation by Downregulating CXCR3/CXCL10 Axis.
    Yue C, Shen S, Deng J, Priceman SJ, Li W, Huang A, Yu H.
    Cancer Immunol Res; 2015 Aug 01; 3(8):864-870. PubMed ID: 26025380
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease.
    Clancy-Thompson E, Perekslis TJ, Croteau W, Alexander MP, Chabanet TB, Turk MJ, Huang YH, Mullins DW.
    Cancer Immunol Res; 2015 Aug 01; 3(8):956-67. PubMed ID: 26048575
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Human T cells armed with Her2/neu bispecific antibodies divide, are cytotoxic, and secrete cytokines with repeated stimulation.
    Grabert RC, Cousens LP, Smith JA, Olson S, Gall J, Young WB, Davol PA, Lum LG.
    Clin Cancer Res; 2006 Jan 15; 12(2):569-76. PubMed ID: 16428502
    [Abstract] [Full Text] [Related]

  • 15. Single cell-produced and in vitro-assembled anti-FcRH5/CD3 T-cell dependent bispecific antibodies have similar in vitro and in vivo properties.
    Ovacik AM, Li J, Lemper M, Danilenko D, Stagg N, Mathieu M, Ellerman D, Gupta V, Kalia N, Nguy T, Plaks V, David Johnson C, Wang W, Brumm J, Fine B, Junttila T, Lin K, Carter PJ, Prabhu S, Spiess C, Kamath AV.
    MAbs; 2019 Jan 15; 11(2):422-433. PubMed ID: 30550367
    [Abstract] [Full Text] [Related]

  • 16. A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma.
    Gedeon PC, Schaller TH, Chitneni SK, Choi BD, Kuan CT, Suryadevara CM, Snyder DJ, Schmittling RJ, Szafranski SE, Cui X, Healy PN, Herndon JE, McLendon RE, Keir ST, Archer GE, Reap EA, Sanchez-Perez L, Bigner DD, Sampson JH.
    Clin Cancer Res; 2018 Aug 01; 24(15):3611-3631. PubMed ID: 29703821
    [Abstract] [Full Text] [Related]

  • 17. Anti-CD3 x anti-HER2 bispecific antibody effectively redirects armed T cells to inhibit tumor development and growth in hormone-refractory prostate cancer-bearing severe combined immunodeficient beige mice.
    Davol PA, Smith JA, Kouttab N, Elfenbein GJ, Lum LG.
    Clin Prostate Cancer; 2004 Sep 01; 3(2):112-21. PubMed ID: 15479495
    [Abstract] [Full Text] [Related]

  • 18. Bispecific Antibody PD-L1 x CD3 Boosts the Anti-Tumor Potency of the Expanded Vγ2Vδ2 T Cells.
    Yang R, Shen S, Gong C, Wang X, Luo F, Luo F, Lei Y, Wang Z, Xu S, Ni Q, Xue Y, Fu Z, Zeng L, Fang L, Yan Y, Zhang J, Gan L, Yi J, Zhou P.
    Front Immunol; 2021 Sep 01; 12():654080. PubMed ID: 34040604
    [Abstract] [Full Text] [Related]

  • 19. Development of a Tetravalent Anti-GPA33/Anti-CD3 Bispecific Antibody for Colorectal Cancers.
    Wu Z, Guo HF, Xu H, Cheung NV.
    Mol Cancer Ther; 2018 Oct 01; 17(10):2164-2175. PubMed ID: 30082472
    [Abstract] [Full Text] [Related]

  • 20. Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3.
    Slaga D, Ellerman D, Lombana TN, Vij R, Li J, Hristopoulos M, Clark R, Johnston J, Shelton A, Mai E, Gadkar K, Lo AA, Koerber JT, Totpal K, Prell R, Lee G, Spiess C, Junttila TT.
    Sci Transl Med; 2018 Oct 17; 10(463):. PubMed ID: 30333240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.